Some studies suggest that anti-inflammatory medications could prevent and treat depression by altering the composition and quantity of beneficial gut bacteria, highlighting the potential of targeting gut microbiota and the NLRP3 inflammasome as strategies for preventing PPD. This evidence concerns the gene NLRP3 and depressive disorder.